Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Wellings

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Cardiovascular Pharmacology|January 1, 1995
Lack of effect of ET antibody or SB 209670 on endotoxin-induced renal failureR P Wellings, R Corder, J R Vane
Journal of the Society for Gynecologic Investigation|March 21, 1998
Activation of endothelial cells by plasma from women with preeclampsia: differential effects on four endothelial cell typesR P Wellings, J C Brockelsby, P N Baker
European Journal of Pharmacology|April 21, 1994
Antagonism of renal and systemic responses to endothelin-1 infusion with PD 145065R P Wellings, R Corder, A M Doherty, et al.
British Journal of Obstetrics and Gynaecology|August 24, 1999
Neutrophil function in women with pre-eclampsiaI P Crocker, R P Wellings, J Fletcher, et al.
American Journal of Obstetrics and Gynecology|November 20, 1998
The role of the endogenous anti-inflammatory compound gravidin in pre-eclampsiaI P Crocker, R P Wellings, R G Hayman, et al.
Journal of Cardiovascular Pharmacology|January 1, 1993
Vasoconstriction in the rat kidney induced by endothelin-1 is blocked by PD 145065R P Wellings, T D Warner, C Thiemermann, et al.
British Journal of Pharmacology|February 1, 1994
Evidence from receptor antagonists of an important role for ETB receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidneyR P Wellings, R Corder, T D Warner, et al.
Journal of the Society for Gynecologic Investigation|June 22, 1999
Endothelial monocyte-activating polypeptide-2 is increased in pregnancy but is not further increased in preeclampsiaR P Wellings, G E Lash, J C Murray, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Cardiovascular Pharmacology|January 1, 1995
Lack of effect of ET antibody or SB 209670 on endotoxin-induced renal failureR P Wellings, R Corder, J R Vane
Journal of the Society for Gynecologic Investigation|March 21, 1998
Activation of endothelial cells by plasma from women with preeclampsia: differential effects on four endothelial cell typesR P Wellings, J C Brockelsby, P N Baker
European Journal of Pharmacology|April 21, 1994
Antagonism of renal and systemic responses to endothelin-1 infusion with PD 145065R P Wellings, R Corder, A M Doherty, et al.
British Journal of Obstetrics and Gynaecology|August 24, 1999
Neutrophil function in women with pre-eclampsiaI P Crocker, R P Wellings, J Fletcher, et al.
American Journal of Obstetrics and Gynecology|November 20, 1998
The role of the endogenous anti-inflammatory compound gravidin in pre-eclampsiaI P Crocker, R P Wellings, R G Hayman, et al.
Journal of Cardiovascular Pharmacology|January 1, 1993
Vasoconstriction in the rat kidney induced by endothelin-1 is blocked by PD 145065R P Wellings, T D Warner, C Thiemermann, et al.
British Journal of Pharmacology|February 1, 1994
Evidence from receptor antagonists of an important role for ETB receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidneyR P Wellings, R Corder, T D Warner, et al.
Journal of the Society for Gynecologic Investigation|June 22, 1999
Endothelial monocyte-activating polypeptide-2 is increased in pregnancy but is not further increased in preeclampsiaR P Wellings, G E Lash, J C Murray, et al.
Pageof 1